妊娠晚期及哺乳期弥漫性大B细胞淋巴瘤病例报告
本文报告一例妊娠晚期诊断的弥漫性大B细胞淋巴瘤病例,患者于34周引产,产后开始标准化疗,并按定时哺乳方案进行母乳喂养。结论强调孕期淋巴瘤管理需综合考量肿瘤与产科护理及新生儿风险,包括分期方法、产前激素使用、分娩时机及化疗期间哺乳。
要点
- 妊娠晚期诊断的弥漫性大B细胞淋巴瘤需多学科协作管理
- 分娩时机与产前激素使用需权衡母胎风险
- 化疗期间哺乳需遵循定时哺乳方案
核心结论
- 孕期淋巴瘤管理需综合考虑肿瘤治疗、产科护理及新生儿风险。
研究设计与样本
- 病例报告:一例妊娠晚期诊断的弥漫性大B细胞淋巴瘤。
主要发现
- 患者于妊娠34周引产,产后开始标准化疗方案。
- 患者按定时哺乳方案进行母乳喂养。
临床怎么用
- 临床需关注分期方法、产前激素使用、分娩时机及化疗期间哺乳等环节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diffuse large B-cell lymphoma is the most common type of non-Hodgkin's lymphoma affecting pregnancy. These tumors may be aggressive and rapidly growing in pregnancy. Management is based on the balance of risks and benefits to both the pregnant patient and the fetus. CASE: We present a case of diffuse large B-cell lymphoma diagnosed in the third trimester of pregnancy. The patient underwent labor induction at 34 weeks of gestation, started a standard chemotherapy protocol postpartum, and breastfed following a timed lactation protocol. CONCLUSION: Management of lymphoma during pregnancy highlights the need to consider all aspects of proposed oncologic and obstetric care as well as neonatal risks. Considerations highlighted in this case include staging methods, administration of antenatal steroids, timing of delivery, and lactation during chemotherapy.
引用
- Hersey AE, Giglio P, Kurt H, et al. Diffuse Large B-Cell Lymphoma During Third-Trimester Pregnancy and Lactation. Obstet Gynecol. 2020. PMID: 31923071. doi:10.1097/AOG.0000000000003654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。